{
    "id": 29622,
    "fullName": "MAP2K1 P105_I107del",
    "impact": "deletion",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "MAP2K1 P105_I107del results in the deletion of three amino acids in the protein kinase domain of the Map2k1 protein from amino acids 105 to 107 (UniProt.org). P105_I107del has been identified in the scientific literature (PMID: 30867592), but has not been biochemically characterized and therefore, its effect on Map2k1 protein function is unknown (PubMed, Oct 2019).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 14632,
                    "pubMedId": 30867592,
                    "title": "Efficacy of MEK inhibition in patients with histiocytic neoplasms.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30867592"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5604,
        "geneSymbol": "MAP2K1",
        "terms": [
            "MAP2K1",
            "CFC3",
            "MAPKK1",
            "MEK1",
            "MKK1",
            "PRKMK1"
        ]
    },
    "variant": "P105_I107del",
    "createDate": "03/28/2019",
    "updateDate": "10/22/2019",
    "referenceTranscriptCoordinates": {
        "id": 178998,
        "transcript": "NM_002755",
        "gDna": "chr15:g.66436768_66436776delCCGCAATCC",
        "cDna": "c.314_322delCCGCAATCC",
        "protein": "p.P105_I107delPAI",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 16577,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase II trial, treatment with Cotellic (cobimetinib) in patients with histiocytic neoplasms resulted in a PET overall response rate of 89% (16/18), with complete response in 72% (13/18) and partial response in 17% (3/18), and resulted in stable disease in 6% (1/18) of patients, including a complete response in a patient with Erdheim-Chester disease harboring MAP2K1 P105_I107del (PMID: 30867592; NCT01953926).",
            "molecularProfile": {
                "id": 31695,
                "profileName": "MAP2K1 P105_I107del"
            },
            "therapy": {
                "id": 1004,
                "therapyName": "Cobimetinib",
                "synonyms": null
            },
            "indication": {
                "id": 60073,
                "name": "lymphatic system cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 14632,
                    "pubMedId": 30867592,
                    "title": "Efficacy of MEK inhibition in patients with histiocytic neoplasms.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30867592"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 31695,
            "profileName": "MAP2K1 P105_I107del",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 179000,
            "transcript": "XM_011521783",
            "gDna": "chr15:g.66436833_66436841delGTGGGCTTC",
            "cDna": "c.313_321delGTGGGCTTC",
            "protein": "p.V105_F107delVGF",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 178998,
            "transcript": "NM_002755",
            "gDna": "chr15:g.66436768_66436776delCCGCAATCC",
            "cDna": "c.314_322delCCGCAATCC",
            "protein": "p.P105_I107delPAI",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 179001,
            "transcript": "XM_017022412",
            "gDna": "chr15:g.66436833_66436841delGTGGGCTTC",
            "cDna": "c.313_321delGTGGGCTTC",
            "protein": "p.V105_F107delVGF",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 179002,
            "transcript": "XM_017022413",
            "gDna": "chr15:g.66485138_66485146delGAGATGCGG",
            "cDna": "c.314_322delGAGATGCGG",
            "protein": "p.G105_A107delGDA",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 178999,
            "transcript": "XM_017022411",
            "gDna": "chr15:g.66436768_66436776delCCGCAATCC",
            "cDna": "c.314_322delCCGCAATCC",
            "protein": "p.P105_I107delPAI",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}